These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4276666)

  • 21. [Renal elimination kinetics of various several cardiac glycosides].
    Kramer P; Scheler F
    Dtsch Med Wochenschr; 1972 Oct; 97(40):1485-90. PubMed ID: 5071762
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of pretreatment with spironolactone, phenobarbital or -diethylaminoethyl diphenylpropylacetate (SKF 525-A) on tritium levels in blood, heart and liver of rats at various times after administration of ( 3 H)digitoxin.
    Castle MC; Lage GL
    Biochem Pharmacol; 1972 May; 21(10):1449-55. PubMed ID: 5029425
    [No Abstract]   [Full Text] [Related]  

  • 23. The binding of 3H-peruvoside by guinea pig isolated atria.
    Kuschinsky K; Lüllmann H; van Zwieten PA
    Arzneimittelforschung; 1968 Dec; 18(12):1602-5. PubMed ID: 5756260
    [No Abstract]   [Full Text] [Related]  

  • 24. [Comparative study of absorption and elimination of tritium-labelled cardiac glycosides].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):206-8. PubMed ID: 5804238
    [No Abstract]   [Full Text] [Related]  

  • 25. Uptake of cardiac glycosides by rabbit and rat myometrium.
    Murthy RV; Kidwai AM; Daniel EE
    J Pharmacol Exp Ther; 1972 Jul; 182(1):166-78. PubMed ID: 4261223
    [No Abstract]   [Full Text] [Related]  

  • 26. Digitoxin metabolism by rat liver homogenates, subcellular fractions and isolated hepatocytes: stimulation by spironolactone and pregnenolone-16 alpha-carbonitrile.
    Castle MC
    J Pharmacol Exp Ther; 1979 Oct; 211(1):120-6. PubMed ID: 40011
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of spironolactone pretreatment on digitoxin metabolism in isolated hepatocytes from male and female rats.
    Ohta M; Sato Y; Kitani K
    Biochem Pharmacol; 1982 Jun; 31(12):2192-4. PubMed ID: 7115439
    [No Abstract]   [Full Text] [Related]  

  • 28. Increased digitoxin cleavage by liver microsomes of spironolactone-pretreated rats.
    Schmoldt A
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Dec; 305(3):261-3. PubMed ID: 740054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intestinal absorption of cardiac glycosides in vitro and in vivo].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biochemical principles of the development of new cardiac drugs of the digitalis type].
    Repke KR
    Pharmazie; 1972 Nov; 27(11):693-701. PubMed ID: 4265944
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of phenobarbital and spironolactone pretreatment on digitoxin-induced mortality in male and female rats.
    Talcott RE; Stohs SJ
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):86-8. PubMed ID: 4746634
    [No Abstract]   [Full Text] [Related]  

  • 32. Proceedings: Pharmacokinetics and metabolism of 4'-methylproscillaridin in man.
    Staud R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R95. PubMed ID: 4276654
    [No Abstract]   [Full Text] [Related]  

  • 33. Disposition of digitoxin in renal failure.
    Vöhringer HF; Rietbrock N; Spurny P; Kuhlmann J; Hampl H; Baethke R
    Clin Pharmacol Ther; 1976 Apr; 19(4):387-95. PubMed ID: 1269191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholestyramine and spironolactone and their combination in digitoxin elimination.
    Carruthers SG; Dujovne CA
    Clin Pharmacol Ther; 1980 Feb; 27(2):184-7. PubMed ID: 7353337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interruption of the enterohepatic circulation of digitoxin by cholestyramine. II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man.
    Caldwell JH; Bush CA; Greenberger NJ
    J Clin Invest; 1971 Dec; 50(12):2638-44. PubMed ID: 5129315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparative study of the resorption, distribution, and excretion of digitalis glycosides in experimental animals].
    Buchtela K; Drexler K; Fehringer A; Hackl H; Königstein M; Schläger J
    Wien Z Inn Med; 1970; 51(5):227-35. PubMed ID: 5535605
    [No Abstract]   [Full Text] [Related]  

  • 37. Biliary excretion of cardiac glycosides.
    Russell JQ; Klaassen CD
    J Pharmacol Exp Ther; 1973 Sep; 186(3):455-62. PubMed ID: 4728329
    [No Abstract]   [Full Text] [Related]  

  • 38. [Metabolism and intestinal absorption of cardiac glycosides].
    Lauterbach F
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199
    [No Abstract]   [Full Text] [Related]  

  • 39. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats].
    Forth W; Furukawa E; Rummel W
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055
    [No Abstract]   [Full Text] [Related]  

  • 40. [Serum half-life and renal clearance of 3H peruvoside. Study on normal persons and patients with terminal kidney insufficiency].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Verh Dtsch Ges Kreislaufforsch; 1969; 35():440-4. PubMed ID: 5380625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.